RT @NicoleKuderer: This reports half of T790M-positive EGFR-mutant #lcsm treated with rociletinib are T790–wild-type upon progression, sugg…
1,927 followers
11,009 followers
This reports half of T790M-positive EGFR-mutant #lcsm treated with rociletinib are T790–wild-type upon progression, suggesting that T790–wild-type clones can emerge as the dominant source of resistance. Plasma ctDNA can sometimes predict emerging resistanc
659 followers
RT @AACR: Celebrating Cancer Discovery’s new 24.373 Impact Factor! Read one of the journal’s highly-cited articles: https://t.co/6bZC86dBO5
1,824 followers
RT @AACR: Celebrating Cancer Discovery’s new 24.373 Impact Factor! Read one of the journal’s highly-cited articles: https://t.co/6bZC86dBO5